Optimizing adjuvant treatment options for patients with glioblastoma

ConclusionOur study suggests that BITES can effectively identify GBM patients likely to benefit from CRT. These ML models show promise in transforming the complex heterogeneity of real-world clinical practice into precise, personalized treatment recommendations.
Source: Frontiers in Neurology - Category: Neurology Source Type: research